MX363827B - Producto para la nutricion parenteral de pacientes obesos en cuidados intensivos. - Google Patents

Producto para la nutricion parenteral de pacientes obesos en cuidados intensivos.

Info

Publication number
MX363827B
MX363827B MX2014000857A MX2014000857A MX363827B MX 363827 B MX363827 B MX 363827B MX 2014000857 A MX2014000857 A MX 2014000857A MX 2014000857 A MX2014000857 A MX 2014000857A MX 363827 B MX363827 B MX 363827B
Authority
MX
Mexico
Prior art keywords
parenteral nutrition
product
care patients
obese intensive
component
Prior art date
Application number
MX2014000857A
Other languages
English (en)
Other versions
MX2014000857A (es
Inventor
Rosa Abele
Ewald Schlotzer
Original Assignee
Fresenius Kabi Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47555035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX363827(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi Deutschland Gmbh filed Critical Fresenius Kabi Deutschland Gmbh
Publication of MX2014000857A publication Critical patent/MX2014000857A/es
Publication of MX363827B publication Critical patent/MX363827B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Pediatric Medicine (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una solución de nutrición parenteral con alto contenido de aminoácidos, bajo contenido de lípidos y bajo contenido de carbohidratos para la administración a pacientes obesos en cuidados intensivos y a una bolsa de tres cámaras que comprende el componente de aminoácidos, el componente de hidratos de carbono y el componente lipidico de la solución de nutrición parenteral por separado en tres diferentes cámaras.
MX2014000857A 2011-07-22 2012-07-19 Producto para la nutricion parenteral de pacientes obesos en cuidados intensivos. MX363827B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161510512P 2011-07-22 2011-07-22
EP11175036 2011-07-22
PCT/EP2012/064220 WO2013014064A1 (de) 2011-07-22 2012-07-19 Produkt zur parenteralen ernährung von adipösen intensivpatienten

Publications (2)

Publication Number Publication Date
MX2014000857A MX2014000857A (es) 2014-04-30
MX363827B true MX363827B (es) 2019-04-03

Family

ID=47555035

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014000857A MX363827B (es) 2011-07-22 2012-07-19 Producto para la nutricion parenteral de pacientes obesos en cuidados intensivos.

Country Status (7)

Country Link
US (2) US20130020226A1 (es)
EP (1) EP2734217B1 (es)
KR (1) KR102007177B1 (es)
CN (1) CN103717230A (es)
BR (1) BR112014001404A2 (es)
MX (1) MX363827B (es)
WO (1) WO2013014064A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160374971A1 (en) 2013-07-01 2016-12-29 The Trustees Of Princeton University Dietary supplements for treating cancer
FR3027074B1 (fr) * 2014-10-14 2016-12-09 Snecma Procede de fabrication d'un palier fluide hydrostatique alveole
CN112402461A (zh) * 2015-11-06 2021-02-26 王益超 一种用于治疗孤独症社会交往障碍的组合物
EP3397960B1 (en) * 2015-12-30 2020-01-29 Société des Produits Nestlé S.A. Method for determining fat free body mass
CA3062798A1 (en) 2017-05-09 2018-11-15 Baxter International Inc. Parenteral nutrition diagnostic system, apparatus, and method
US20210212936A1 (en) * 2018-06-01 2021-07-15 Baxter International Inc. Parenteral nutrition formulation
US11278510B2 (en) 2019-09-05 2022-03-22 Baxter International Inc. Parenteral nutrition formulation with optimized amino acid and glucose content
WO2023117871A1 (en) * 2021-12-21 2023-06-29 Fresenius Kabi Deutschland Gmbh Compositions for providing parenteral nutrition to pediatric patients

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189016A (en) * 1990-05-18 1993-02-23 Clintec Nutrition Co. Nutrient compositions containing peptides and method for administering the same
EP0831728A2 (en) * 1995-06-06 1998-04-01 Campbell Soup Company Mineral supplements for dietetic food
US6039989A (en) 1995-06-06 2000-03-21 Campbell Soup Company Prepackaged therapeutic meal for treatment of diet-responsive conditions
ZA978002B (en) * 1996-09-11 1998-03-02 Baxter Int Containers and methods for storing and admixing medical solutions.
GB0229838D0 (en) 2002-12-20 2003-01-29 Mars Uk Ltd Multi-component meal
JP2007517026A (ja) * 2003-12-24 2007-06-28 エヌ.ブイ.・ヌートリシア パントテン酸又はその誘導体を含む組成物、及び食欲を増進するためのその使用
WO2005096845A1 (en) 2004-04-09 2005-10-20 N.V. Nutricia Liquid concentrated formula
ES2402935T3 (es) * 2005-03-21 2013-05-10 Abbott Laboratories Composición de aminoácidos para mejorar la tolerancia a la glucosa
CA2631220A1 (en) 2006-01-09 2007-07-19 Nestec S.A. Treatment of stressed patients

Also Published As

Publication number Publication date
KR102007177B1 (ko) 2019-08-05
EP2734217A1 (de) 2014-05-28
KR20140060503A (ko) 2014-05-20
US20140205673A1 (en) 2014-07-24
EP2734217B1 (de) 2020-12-02
US20130020226A1 (en) 2013-01-24
MX2014000857A (es) 2014-04-30
CN103717230A (zh) 2014-04-09
WO2013014064A1 (de) 2013-01-31
BR112014001404A2 (pt) 2017-03-01

Similar Documents

Publication Publication Date Title
MX363827B (es) Producto para la nutricion parenteral de pacientes obesos en cuidados intensivos.
USD671178S1 (en) Static frame abdominal exercise apparatus
MX342675B (es) Formulaciones estables para inyeccion parenteral de farmacos de peptido.
EP2567700A4 (en) NUTRIENT PERFUSION CONTAINING VITAMINS FOR PERIPHERAL VENOUS DELIVERY
EP3795194C0 (de) Injektionsgerät zur verabreichung oder förderung von fluidem produkt
EP2809385A4 (en) VALVE ASSEMBLY FOR ENTERAL FOOD ADMINISTRATION
WO2012174158A3 (en) Administration of benzodiazepine
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
MX2014002159A (es) Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2.
HK1248987A1 (zh) 可溶性大豆蛋白產品("s704")的生產
MY182320A (en) Downstream process
WO2013056048A3 (en) Nutritional products comprising beta-alanine
MX2013013512A (es) Alimento medico para deterioro cognitivo.
PH12014502071A1 (en) Beta-hydroxy-beta-methylbutyric acid for imrpoving glucose tolerance
WO2013032558A3 (en) Products for anti-inflammation support
EP2928458A4 (en) SPERMIDINE / SPERMIN N'-ACETYLTRANSFERASE SUBSTRATES AS ANTICANCER DRUG COMPOUNDS
IN2015DN02999A (es)
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
MX2020007270A (es) Formulacion parenteral que comprende siponimod.
BR112014000599A2 (pt) sistema dietético multicomponentes
MX2015013158A (es) Metodo y productos para mejorar la biodisponibilidad de los farmacos y de los suplementos dieteticos.
WO2013093458A3 (en) Antiviral compounds
WO2011061687A3 (en) Multiple-phase dietary supplement product
MY167577A (en) Novel powdered milk product and method for producing the same
ZA201208299B (en) Infant nutrition product

Legal Events

Date Code Title Description
FG Grant or registration